Last reviewed · How we verify
NCT06865313
Functional Evaluation After Maxillectomy and Scapular Free Flap Reconstruction
trial in Maxillary Sinus Squamous Cell Carcinoma in 16 participants. Completed in 30 June 2023.
1 March 2023
Quick facts
| Lead sponsor | Hôpital de la Croix-Rousse |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 16 |
| Start date | 1 March 2023 |
| Primary completion | 1 March 2023 |
| Estimated completion | 30 June 2023 |
| Sites | 1 location across France |
Conditions studied
- Maxillary Sinus Squamous Cell Carcinoma — all drugs for Maxillary Sinus Squamous Cell Carcinoma →
Sponsor
Hôpital de la Croix-Rousse
Who can join
18 and older, any sex, with Maxillary Sinus Squamous Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the study is to analyse the functional and aesthetic outcomes after removal of the maxillar bone and reconstruction with part of the scapular bone for people having maxillary tumor
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06865313
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Maxillary Sinus Squamous Cell Carcinoma
Currently open trials in the same condition.
- NCT05172245 — Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · Phase 1 · recruiting
Other Hôpital de la Croix-Rousse trials
Trials by the same sponsor.
- NCT05365074 — Intrathecal Chloroprocaine for Lower Limb Arthroplasty · completed
- NCT03635944 — Nutritional Care and Head Growth in Preterm Infants · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06865313 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital de la Croix-Rousse
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06865313.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing